ZHIDA TECH (02650) "1 to 5" implemented today, liquidity is expected to be further released.
On March 3, Zhida Technology (02650) officially implemented the share splitting plan approved at the previous extraordinary general meeting of shareholders. According to the announcement, each existing H share with a face value of RMB 1.00 has been split into five H shares with a face value of RMB 0.20. The split H shares began trading at 9:00 am on March 3.
On March 3rd, ZHIDA TECH (02650) officially implemented the stock split plan approved at the previous extraordinary general meeting of shareholders. According to the announcement, each existing H share with a face value of RMB 1.00 was split into five H shares with a face value of RMB 0.20, and the split H shares began trading at 9 am on March 3rd.
On February 13th, ZHIDA TECH held an extraordinary general meeting of shareholders to vote on a special resolution regarding the stock split and corresponding amendments to the articles of association. Shareholders and authorized representatives with a total of 33,636,010 H shares, accounting for approximately 56.26% of the total issued H shares, attended the meeting. The results showed unanimous approval with no opposing or abstaining votes. With support from over two-thirds of the votes, the resolution was formally adopted.
The company stated that after the stock split takes effect, assuming no further issuance, repurchase, or cancellation of existing H shares between the announcement date and the effective date of the stock split, 298,944,035 split H shares will be issued and fully paid up. The new split H shares will be printed in yellow, and the original blue shares will no longer be used for trading, settlement, or registration purposes after 4:10 pm on the same day but will remain valid as proof of ownership.
For investors, the lower face value per share after the split reduces the trading threshold and is expected to enhance liquidity. This change not only provides more flexible entry opportunities for small and medium investors but also attracts more attention to the development potential of the company in the field of new energy charging equipment.
Related Articles

MNSO (09896) spent $222,500 to repurchase 51,300 shares on March 2nd.

SSY GROUP(02005): Obtained drug manufacturing registration for 5ml:100mg injection of dexmedetomidine hydrochloride.
Oppenheimer March US stock strategy: Momentum strategy is timely, recommending stocks such as Apple Inc. (AAPL.US), Alcoa Corporation (AA.US), Baker Hughes (BKR.US), etc.
MNSO (09896) spent $222,500 to repurchase 51,300 shares on March 2nd.

SSY GROUP(02005): Obtained drug manufacturing registration for 5ml:100mg injection of dexmedetomidine hydrochloride.

Oppenheimer March US stock strategy: Momentum strategy is timely, recommending stocks such as Apple Inc. (AAPL.US), Alcoa Corporation (AA.US), Baker Hughes (BKR.US), etc.
RECOMMEND





